JPH03180188A - Production of cysteine - Google Patents
Production of cysteineInfo
- Publication number
- JPH03180188A JPH03180188A JP31734489A JP31734489A JPH03180188A JP H03180188 A JPH03180188 A JP H03180188A JP 31734489 A JP31734489 A JP 31734489A JP 31734489 A JP31734489 A JP 31734489A JP H03180188 A JPH03180188 A JP H03180188A
- Authority
- JP
- Japan
- Prior art keywords
- cystine
- cysteine
- reaction
- enzyme solution
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000018417 cysteine Nutrition 0.000 title claims description 28
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 title claims description 28
- 238000004519 manufacturing process Methods 0.000 title claims description 16
- 229960003067 cystine Drugs 0.000 claims abstract description 31
- 108010020056 Hydrogenase Proteins 0.000 claims abstract description 15
- 230000000694 effects Effects 0.000 claims abstract description 15
- 244000005700 microbiome Species 0.000 claims abstract description 10
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 claims abstract description 7
- 239000005515 coenzyme Substances 0.000 claims abstract description 5
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims abstract 3
- 108090000790 Enzymes Proteins 0.000 claims description 23
- 102000004190 Enzymes Human genes 0.000 claims description 23
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 239000003513 alkali Substances 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 239000007788 liquid Substances 0.000 abstract description 4
- 241000193459 Moorella thermoacetica Species 0.000 abstract description 3
- 239000007853 buffer solution Substances 0.000 abstract description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 abstract description 2
- 229950006238 nadide Drugs 0.000 abstract description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 abstract description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 26
- 229940088598 enzyme Drugs 0.000 description 21
- 238000000034 method Methods 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 10
- 239000007789 gas Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 241000205276 Methanosarcina Species 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 229930014626 natural product Natural products 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- -1 electricity storage Natural products 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- HXFCUMCLVYNZDM-UHFFFAOYSA-N 2-aminoacetic acid;sodium Chemical compound [Na].NCC(O)=O HXFCUMCLVYNZDM-UHFFFAOYSA-N 0.000 description 1
- 241000589151 Azotobacter Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 102100030012 Deoxyribonuclease-1 Human genes 0.000 description 1
- 101710206036 Deoxyribonuclease-1 Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000003411 electrode reaction Methods 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はシスティンの製造法に関し、更に詳細には耐ア
ルカリ性ヒドロゲナーゼ活性を有する酵素液を用いて、
シスチンからシスティンを高収率で生産する方法に関す
る。[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to a method for producing cysteine, more specifically, using an enzyme solution having alkaline-resistant hydrogenase activity,
This invention relates to a method for producing cystine from cystine in high yield.
〔従来の技術及び〜発明が解決しようとする課題〕シス
ティ・ンはメルカプト基を有するアミノ酸であり、医薬
、医薬原料、食品添加物、飼料添加物及び化粧品添加物
等多方面に使用され、特に近年はコールドパーマ液の原
料として需要が増加している。[Prior art and problems to be solved by the invention] Cysteine is an amino acid with a mercapto group, and is used in a wide variety of fields such as medicines, pharmaceutical raw materials, food additives, feed additives, and cosmetic additives. In recent years, demand has increased as a raw material for cold perm liquid.
従来、システィンの製造法としては天然物からの抽出法
、有機合成法、発酵法及び酵素法が知られている。天然
物からの抽出法は、毛髪等のシスチンやシスティンの含
有の高い天然物を塩酸で加水分解し、生じたアミノ酸混
液より抽出分離したシスチンを電気還元してシスティン
を得るものである。しかしこの抽出法は電極反応により
他の不純物が生成するため、特に医薬、食品添加物とし
て用いるには適していない。また電気還元には多量の電
力及び電解質を必要とするため高コストになるという難
点があった。有機合成法には実用的なものは開示されて
おらず、これらの方法に代えて発酵法(特開昭59−2
8485号)が提案され・ているが、原料が高価である
こと、システィンの生産量が充分でないこと、菌が生産
する不純物に対する精製が困難であること、菌の管理が
むずかしいこと等の難点がある。また酵素法(特開昭6
3−7790号)も提案されているが、システィンの生
産量が低く有効な製造法とはなっていない。Conventionally, known methods for producing cysteine include extraction methods from natural products, organic synthesis methods, fermentation methods, and enzymatic methods. The extraction method from natural products involves hydrolyzing cystine or natural products with a high cysteine content, such as hair, with hydrochloric acid, and electroreducing the extracted cystine from the resulting amino acid mixture to obtain cystine. However, this extraction method produces other impurities due to the electrode reaction, so it is not particularly suitable for use as a medicine or food additive. In addition, electric reduction requires a large amount of electricity and electrolyte, resulting in high cost. No practical organic synthesis methods have been disclosed, and instead of these methods, the fermentation method (Japanese Unexamined Patent Publication No. 59-2
No. 8485) has been proposed, but it has drawbacks such as expensive raw materials, insufficient production of cysteine, difficulty in purifying impurities produced by bacteria, and difficulty in controlling bacteria. be. Also, the enzymatic method (Unexamined Japanese Patent Publication No. 6)
No. 3-7790) has also been proposed, but the production amount of cysteine is low and it is not an effective manufacturing method.
そこで本発明者らは、さきにヒドロゲナーゼ活性を有す
る酵素液の存在下、シスチンに水素を反応させてシステ
ィンを製造する方法(特願昭63−247052号)を
開発した。この製造方法によれば、シスチンからシステ
ィンを高収率、高純度に製造することができる。しかし
ながら、この方法は反応速度に難点があり、工業的製法
として必ずしも充分満足し得るものではなかった。Therefore, the present inventors first developed a method for producing cystine by reacting cystine with hydrogen in the presence of an enzyme solution having hydrogenase activity (Japanese Patent Application No. 63-247052). According to this production method, cysteine can be produced from cystine with high yield and high purity. However, this method has a drawback in the reaction rate and is not necessarily fully satisfactory as an industrial production method.
従って、より工業的に有利なシスティンの製造方法の開
発が熱望されていた。Therefore, the development of a more industrially advantageous method for producing cysteine has been eagerly awaited.
上記実情に鑑み本発明者らは、従来のヒドロゲナーゼ活
性を有する酵素液による反応はヒドロゲナーゼを得た微
生物の最適p)l付近で行なうことが好ましいという考
えに拘泥することなく鋭意研究を行なった結果、特定の
微生物から得られる酵素液が当該微生物の最適pH付近
でないアルカリ性領域でも反応が良好に行なわれること
、更にこの酵素液の存在下、アルカリ領域にてシスチン
に水素を反応させれば工業的に有利にシスティンを製造
できることを見出し本発明を完成した。In view of the above-mentioned circumstances, the present inventors have conducted intensive research without being bound to the idea that it is preferable to conduct a reaction using a conventional enzyme solution having hydrogenase activity at a value near the optimum p)l of the microorganism from which the hydrogenase was obtained. The fact that the enzyme solution obtained from a specific microorganism can perform a good reaction even in an alkaline region that is not near the optimum pH of the microorganism, and furthermore, if hydrogen is reacted with cystine in an alkaline region in the presence of this enzyme solution, it can be used industrially. They discovered that cysteine can be produced advantageously and completed the present invention.
すなわち、本発明は耐アルカリヒドロゲナーゼ活性を有
する酵素液の存在下、アルカリ性領域にてシスチンに水
素を反応させることを特徴とするシスティンの製造法を
提供するものである。That is, the present invention provides a method for producing cystine, which is characterized by reacting cystine with hydrogen in an alkaline region in the presence of an enzyme solution having alkali-resistant hydrogenase activity.
本発明方法の原料であるシスチンはL体、D体又はDL
体のいずれであってもよい。Cystine, which is a raw material for the method of the present invention, is L-form, D-form or DL-form.
It can be any part of the body.
本発明で使用する酵素液は耐アルカリ性ヒドロゲナーゼ
活性を有するものであれば特に限定されず、耐アルカリ
性ヒドロゲナーゼを溶解させた液でも、耐アルカリ性ヒ
ドロゲナーゼ活性を有する微生物の培養物でもよい。耐
アルカリ性ヒドロゲナーゼ活性を有する微生物の培養物
としては、例えばクロストリジウム(Clostrid
ium)、大腸菌、硫酸還元菌、メタン菌、水素細菌、
アゾトバクタ−(^zotobacter)等に属する
菌の培養物が挙げられる。かかる培養物としては例えば
、これらの菌を常法に・より培養し、遠心分離機等で集
菌したものを超音波破壊処理し、遠心分離した上澄を用
いるのが好ましい。酵素液の添加量は、シスチンを含む
緩衝液に対するタンパク換算で約0.01wt%以上、
特に約0.05wt%以上、更に約0.05〜t Ow
t%が好ましい。反応は、反応速度を向上させるため水
素分圧が高い状態で行なうのが好ましい。なお、耐アル
カリ性ヒドロゲナーゼを得た微生物が嫌気性菌である場
合には、気相を嫌気性すなわち酸素を含まない状態にす
る必要がある。The enzyme solution used in the present invention is not particularly limited as long as it has an alkali-resistant hydrogenase activity, and may be a solution in which an alkali-resistant hydrogenase is dissolved or a culture of a microorganism that has an alkali-resistant hydrogenase activity. As a culture of a microorganism having alkaline-resistant hydrogenase activity, for example, Clostridium
ium), Escherichia coli, sulfate-reducing bacteria, methane bacteria, hydrogen bacteria,
Examples include cultures of bacteria belonging to Azotobacter and the like. As such a culture, it is preferable to use, for example, a supernatant obtained by culturing these bacteria by a conventional method, collecting the bacteria using a centrifuge or the like, subjecting them to ultrasonic destruction, and centrifuging them. The amount of the enzyme solution added is about 0.01 wt% or more in terms of protein based on the buffer solution containing cystine.
Particularly about 0.05 wt% or more, and even about 0.05 to t Ow
t% is preferred. The reaction is preferably carried out under a high hydrogen partial pressure in order to improve the reaction rate. In addition, when the microorganism from which the alkali-resistant hydrogenase was obtained is an anaerobic bacterium, it is necessary to make the gas phase anaerobic, that is, an oxygen-free state.
反応温度は、微生物の培養物を用いる場合、該微生物の
最適生育温度の約8時間以内、特に約8時間以内とする
ことが好ましい。例えばクロストリジウム サーモアセ
チカム(Clostridium45〜65℃、メタノ
サルシナ パルケリ(Methanosarcina
barkeri)DSM 804を用いた場合は約32
〜42℃が好ましい。反応時間はバッチ法で反応させた
場合、通常約8時間以内であるが、他の条件の変更に応
じて適切な反応時間を選択できる。また生産されたシス
ティンを連続的に取り出すことにより、反応を連続して
行なうこともできる。When using a culture of microorganisms, the reaction temperature is preferably within about 8 hours, particularly within about 8 hours, of the optimal growth temperature of the microorganisms. For example, Clostridium thermoaceticum (45-65℃), Methanosarcina parkeri (Methanosarcina
32 when using DSM 804
~42°C is preferred. The reaction time is usually about 8 hours or less when the reaction is carried out by a batch method, but an appropriate reaction time can be selected depending on changes in other conditions. Furthermore, the reaction can be carried out continuously by continuously taking out the produced cysteine.
本発明は反応をアルカリ性領域において行なうことが特
徴であり、これによりシスチンの溶解度を増加させ、反
応を速めることができる。ここでアルカリ性領域とはp
H約8以上である領域をいうが、好ましくはシスチンの
溶解度が充分となるpH約9以上である。反応液のpH
は酵素液が失活しない限り高くすることができるが、通
常約12以下とすることが好ましい。The present invention is characterized in that the reaction is carried out in an alkaline region, thereby increasing the solubility of cystine and speeding up the reaction. Here, the alkaline region is p
This refers to a pH range of about 8 or higher, preferably about 9 or higher where cystine has sufficient solubility. pH of reaction solution
can be increased as long as the enzyme solution is not deactivated, but it is usually preferably about 12 or less.
本発明においては、補酵素又はメチルビオロゲンを加え
れば、反応が更に促進される。補酵素としては、例えば
F420 [N−(N−[0−[5−(8−ヒドロキシ
−5−デアザイソアロキサジン−10−イル)−2,3
,4−)リヒドロキシー4−ペントキシヒドロキシホス
フィニル]−L−ラクチル〕−γ−L−グ、ルタミル〕
−L−グルタミン酸〕、N^0+〔ニコチンアミドアデ
ニンジヌクレオチド〕等が用いられる。補酵素またはメ
チルビオロゲンの添加量は、シスチンを含む緩衝液に対
し約0.005JJmoIl/ 1以上、特ニ約0.0
1pmoll/1以上、更に約0. Ofμmol /
1〜20mmoj!/j!が好ましい。In the present invention, the reaction is further promoted by adding a coenzyme or methyl viologen. As a coenzyme, for example, F420 [N-(N-[0-[5-(8-hydroxy-5-deazaiisoalloxazin-10-yl)-2,3
,4-)lihydroxy-4-pentoxyhydroxyphosphinyl]-L-lactyl]-γ-L-g, rutamyl]
-L-glutamic acid], N^0+ [nicotinamide adenine dinucleotide], etc. are used. The amount of coenzyme or methyl viologen added is about 0.005 JJmol/1 or more, especially about 0.0 to the buffer solution containing cystine.
1 pmol/1 or more, furthermore about 0. Ofμmol/
1~20 mmoj! /j! is preferred.
本発明は、次のような特有の効果をもつ産業上利用価値
の高いすぐれたシスティンの製造法である。The present invention is an excellent method for producing cysteine that has the following unique effects and is of high industrial value.
(1)蓄電等の天然物として自然界に安価で多数存在す
るシスチンを原料とすることができるので、低コストで
安定的にシスティンを製造することができる。(1) Cystine, which is inexpensive and exists in abundance in nature as a natural product such as electricity storage, can be used as a raw material, so cystine can be stably produced at low cost.
(2)従来の電気還元法では、多量の電力及び電解液を
必要とし、高コストになっていたが、本発明法ではきわ
めて低コストでシスティンを製造できる。(2) Conventional electrical reduction methods require large amounts of electricity and electrolyte, resulting in high costs, but the method of the present invention allows cysteine to be produced at extremely low costs.
(3)従来の電気還元法では不可能であった医薬、食品
添加物として利用することのできる高純度のシスティン
を製造できる。(3) It is possible to produce highly pure cysteine that can be used as a pharmaceutical or food additive, which was not possible using conventional electroreduction methods.
(4) シスチンの溶解度の高いアルカリ性において
反応を行なわせることができるため反応装置がきわめて
小型化でき、また生産性を飛躍的に向上させることがで
きる。(4) Since the reaction can be carried out in an alkaline environment where cystine has a high solubility, the reaction apparatus can be extremely miniaturized and productivity can be dramatically improved.
以下に実施例を示して本発明を更に具体的に説明するが
、これらは単に例示の目的でかかげるものであって、本
発明がこれらに限定されるものではない。EXAMPLES The present invention will be described in more detail with reference to Examples below, but these are merely given for the purpose of illustration and the present invention is not limited thereto.
実施例1
グリコースを単一炭素源とする最少培地で60℃、pH
7,0の嫌気条件下でクロストリジウム サーモアセチ
カムATCC31490を4日間バッチ培養した。培養
物から遠心分離により菌体を集菌し、トリス塩酸塩緩衝
液で洗浄後、リゾチーム及びデオキシリボヌクレアーゼ
1を含む溶液で37℃、90分間反応させることにより
菌体を破壊し、遠心分離した上澄を酵素液とした。この
酵素液の製造及び保存はすべて嫌気的に行なった。この
酵素液ヲ、シスチン3 mmoj! / 1の割合で含
む濃度50 mmof / Il、pH9のトリス塩酸
塩B衝液4mt’に対してタンパク換算で3■の割合で
添加した。Example 1 Minimal medium with glycose as the sole carbon source at 60°C and pH
Clostridium thermoaceticum ATCC31490 was batch cultured for 4 days under anaerobic conditions of 7.0. Bacterial cells were collected from the culture by centrifugation, washed with Tris-hydrochloride buffer, destroyed by reacting with a solution containing lysozyme and deoxyribonuclease 1 at 37°C for 90 minutes, and then centrifuged. The clear solution was used as an enzyme solution. The production and storage of this enzyme solution were all carried out anaerobically. This enzyme solution has cystine 3 mmoj! It was added at a ratio of 3 μm in terms of protein to 4 mt' of Tris hydrochloride B solution containing 50 mmof/Il and pH 9 at a ratio of 3 μm/Il.
気相をH,:N、=3 : 1 (溶量比)のガス3
気圧で封入し、温度55℃で振とうしながら5時間反応
させた。ガイトンデ(Gaitonde)法を用いてシ
スティンの定量を行なったところシスチンのシスティン
への還元率は50.2%であった。The gas phase is H, :N, = 3 : 1 (molten ratio) gas 3
It was sealed under atmospheric pressure and reacted for 5 hours with shaking at a temperature of 55°C. When cysteine was quantified using the Gaitonde method, the reduction rate of cysteine to cysteine was 50.2%.
比較例1
酵素液を121℃にて15分間加熱して、酵素活性を失
わせたものを酵素液の代わりに用いたこと以外は、実施
例1と同様にして実施した。この場合シスチンのシステ
ィンへの還元率は0.4%であった。Comparative Example 1 A test was carried out in the same manner as in Example 1, except that the enzyme solution was heated at 121° C. for 15 minutes to lose enzyme activity and used instead of the enzyme solution. In this case, the reduction rate of cystine to cysteine was 0.4%.
この結果、この比較例1と比較して、実施例1では酵素
反応によりシスチンからシスティンの還元が行なわれて
いることがわかる。As a result, compared with Comparative Example 1, it can be seen that in Example 1, reduction of cystine to cysteine was carried out by an enzymatic reaction.
実施例2
メチルビオロゲンを0.1mmo 1 / 1の割合で
添加し、反応時間を変化させたこと以外は実施例1と同
様に実施した。その結果を表1に示す。Example 2 The same procedure as Example 1 was carried out except that methyl viologen was added at a ratio of 0.1 mmol 1/1 and the reaction time was varied. The results are shown in Table 1.
表1
実施例1と比較してメチルビオロゲンを添加することに
より反応が促進されていることがわかる。Table 1 Compared to Example 1, it can be seen that the reaction was accelerated by adding methyl viologen.
参考例1
メタノールを単一炭素源とする最少培地で、37℃、p
H6,7の嫌気性条件下でメタノサルシナバルケIJ
DSM 804を3日間培養した。培養物から遠心分
離により菌体を集菌し、トリス塩酸塩緩衝液で洗浄後、
冷却下超音波処理して菌体を破壊し、更に遠心分離した
上澄を酵素液とした。この酵素液の製造及び保存はすべ
て嫌気的に行なった。Reference Example 1 A minimal medium with methanol as the sole carbon source, 37°C, p
Methanosarcina Balke IJ under anaerobic conditions of H6,7
DSM 804 was cultured for 3 days. Collect bacterial cells from the culture by centrifugation, wash with Tris-HCl buffer,
The bacterial cells were destroyed by ultrasonic treatment under cooling, and the supernatant obtained by centrifugation was used as an enzyme solution. The production and storage of this enzyme solution were all carried out anaerobically.
この酵素液をシスチン3fflIII01/1の割合で
含む濃度50 mmoj! / 1、pH7のしリス塩
酸塩緩衝液4ml!に対してタンパク換算で3■添加し
更にメチルビオロゲンを0.1mmoj! / 1の割
合で添加した。Contains this enzyme solution at a ratio of cystine 3fflIII01/1 at a concentration of 50 mmoj! / 1. 4ml of pH 7 salt hydrochloride buffer! Added 3■ in terms of protein and added 0.1 mmoj of methyl viologen! /1.
気相をH,:N2=3 : 1 (容量比)のガスで
3気圧に封入し、温度37℃で振とうしながら2時間反
応させた。ガイトンデ(Gaitonde)法を用いて
システィンの定量を行なったところ、生産されたシステ
ィン量は1.Ommo 1 / Il 、還元率は16
.7%であった。The gas phase was sealed at 3 atm with a gas of H,:N2=3:1 (volume ratio), and reacted for 2 hours with shaking at a temperature of 37°C. When cysteine was quantified using the Gaitonde method, the amount of cysteine produced was 1. Ommo 1/Il, reduction rate is 16
.. It was 7%.
実施例2と比較して本方法では、1.0mmoj!のシ
スティンを得るために40倍もの時間が必要であった。Compared to Example 2, this method has a reduction of 1.0 mmoj! It took 40 times as long to obtain cysteine.
また、本方法では、シスチンの溶解度が充分でなく、反
応液中にシスチン粒子が懸濁している状態であった。Furthermore, in this method, the solubility of cystine was not sufficient, and cystine particles were suspended in the reaction solution.
参考例2
シスチン濃度を1 mmoj! / l s反応時間を
6時間とした以外は参考例1と同様に実施したところ、
生産されたシスティン量は、0.96mmoj! /
1、還元率は48%であった。Reference example 2 Cystine concentration is 1 mmoj! The same procedure as in Reference Example 1 was carried out except that the reaction time was 6 hours.
The amount of cysteine produced was 0.96 mmoj! /
1. The return rate was 48%.
実施例3
メタノールを単一炭素源とする最少培地で30t、pH
6,7の嫌気条件下でメタノサルシナバシルケ’) D
SM 804を3日間培養した。培養物から遠心分離に
より集菌し、トリス塩酸塩緩衝液で洗浄後、冷却下超音
波処理して菌体を破壊し、更に遠心分離した上澄を酵素
液とした。この酵素液の製造保存はすべて嫌気的に行な
った。この酵素液をシスチン1mmoIlの割合で含む
p)19のトリス塩酸塩緩衝液4−及びシスチンl @
moj! / 1の割合で含むpH10のグリシン水酸
化ナトリウム塩緩衝液4mj!に対してそれぞれタンパ
ク換算で3■の割合で添加した。気相をHs:N*=3
: 1 (容量比)のガスで3気圧に封入し、温度
37℃で振とうしながら2時間反応させた。生産された
システィン量をガイトンデ法を用いて定量したところ、
両方ともシスティン量2. Ommo 1 / j!
、還元率100%であった。参考例2と比較してアルカ
リ領域で反応させることにより反応が促進されているこ
とがわかる。Example 3 Minimal medium with methanol as sole carbon source, 30t, pH
Methanosarcina basilce under anaerobic conditions of 6, 7) D
SM 804 was cultured for 3 days. Bacteria were collected from the culture by centrifugation, washed with Tris-hydrochloride buffer, treated with ultrasonic waves under cooling to destroy the bacterial cells, and the centrifuged supernatant was used as an enzyme solution. This enzyme solution was manufactured and stored in an anaerobic manner. p) 19 Tris-hydrochloride buffer 4- and cystine l containing this enzyme solution at a ratio of 1 mmol cystine @
moj! / 4 mj of pH 10 glycine hydroxide sodium salt buffer containing at a ratio of 1! Each was added at a ratio of 3 μm in terms of protein. Gas phase Hs:N*=3
: 1 (volume ratio) gas was sealed at 3 atm, and reacted at a temperature of 37° C. for 2 hours with shaking. When the amount of cysteine produced was quantified using the Gaitonde method,
Both cysteine amount 2. Ommo 1/j!
, the return rate was 100%. It can be seen that the reaction was accelerated by reacting in the alkaline region compared to Reference Example 2.
以 上Below Up
Claims (1)
在下、アルカリ性領域にてシスチンに水素を反応させる
ことを特徴とするシステインの製造法。 2、耐アルカリヒドロゲナーゼ活性を有する酵素液が、
ヒドロゲナーゼ活性を有する微生物の培養物である請求
項1記載のシステインの製造法。 3、更に補酵素又はメチルビオロゲンを添加して反応さ
せることを特徴とする請求項1又は2記載のシステイン
の製造法。[Claims] 1. A method for producing cysteine, which comprises reacting cystine with hydrogen in an alkaline region in the presence of an enzyme solution having alkali-resistant hydrogenase activity. 2. An enzyme solution having alkali-resistant hydrogenase activity,
The method for producing cysteine according to claim 1, which is a culture of a microorganism having hydrogenase activity. 3. The method for producing cysteine according to claim 1 or 2, characterized in that the reaction is carried out by further adding a coenzyme or methyl viologen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP31734489A JPH03180188A (en) | 1989-12-06 | 1989-12-06 | Production of cysteine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP31734489A JPH03180188A (en) | 1989-12-06 | 1989-12-06 | Production of cysteine |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03180188A true JPH03180188A (en) | 1991-08-06 |
Family
ID=18087176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP31734489A Pending JPH03180188A (en) | 1989-12-06 | 1989-12-06 | Production of cysteine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03180188A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011039156A1 (en) | 2009-09-29 | 2011-04-07 | Dsm Ip Assets B.V. | Process for producing cysteine and/or glutathione from cystine employing yeast |
WO2018114575A1 (en) * | 2016-12-22 | 2018-06-28 | Dsm Ip Assets B.V. | Enzymatic reduction of cystine |
-
1989
- 1989-12-06 JP JP31734489A patent/JPH03180188A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011039156A1 (en) | 2009-09-29 | 2011-04-07 | Dsm Ip Assets B.V. | Process for producing cysteine and/or glutathione from cystine employing yeast |
WO2018114575A1 (en) * | 2016-12-22 | 2018-06-28 | Dsm Ip Assets B.V. | Enzymatic reduction of cystine |
CN110087488A (en) * | 2016-12-22 | 2019-08-02 | 帝斯曼知识产权资产管理有限公司 | The enzymatic reduction of cystine |
US11098332B2 (en) | 2016-12-22 | 2021-08-24 | Dsm Ip Assets B.V. | Enzymatic reduction of cystine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11113588A (en) | Production of oxygen-containing compound | |
JPH03180188A (en) | Production of cysteine | |
JPH04304893A (en) | Production of hydroxide of nitrogen-containing heterocyclic compound by microorganism | |
JPH0292294A (en) | Production of cysteine | |
JP2006067870A (en) | New aminoacylase and method for producing the same, and method for producing amino acid derivative by utilizing the new aminoacylase | |
JPH04304894A (en) | Production of hydroxide of picolinic acid or pyrazinic acid by microorganism | |
JP4485734B2 (en) | 5-substituted hydantoin racemase, DNA encoding the same, recombinant DNA, transformed cell, and method for producing optically active amino acid | |
KR950005424B1 (en) | Process for producing l-aspartyl-l-phenylalanine and its diketo piperazine | |
JPS5816692A (en) | Preparation of l-tryptophan by enzyme | |
JP3233878B2 (en) | Method for producing L-aspartic acid | |
JPS592693A (en) | Biological method for preparing amide | |
JP3873512B2 (en) | Method for producing D-3- (2-naphthyl) alanine | |
Santoyo et al. | Growth kinetics of L-aminoacylase-producing Pseudomonas sp. BA2 | |
JP2716477B2 (en) | Method for producing S-carboxymethyl-L-cysteine | |
JPS5939296A (en) | Preparation of l-tryptophan using bacterium | |
JPH06102027B2 (en) | Method for producing L-2-amino-4-phenylbutyric acid | |
JP2901458B2 (en) | Method for producing gentianose | |
CN117448309A (en) | Preparation method of immobilized sea weed enzyme and application of immobilized sea weed enzyme in pregabalin intermediate | |
CN118272325A (en) | Amino substitution enzyme mutant, complex enzyme, immobilized enzyme and preparation method of ergothioneine | |
JPH0346115B2 (en) | ||
JPS60176594A (en) | Preparation of l-tryptophan | |
JPS62143690A (en) | Production of sulfur-containing l-amino acid by enzymatic process | |
JPH0630572B2 (en) | L-phenylalanine dehydrogenase | |
JPH0349555B2 (en) | ||
JPS5928489A (en) | Preparation of 2,2-dimethylthiazolidine-4-carboxylic acid |